1. Aspects of allograft rejection. IV. Evaluation of new pharmacologic agents for prevention of allograft rejection;Halloran;Transplant Rev,1995
2. In vivo (Phase I) trial and in vitro efficacy of humanized anti-Tac for the prevention of rejection in renal transplant recipients;Stock;Transplant Proc,1996
3. Prolonged immunosuppressive effect and minimal immunogenicity from chimeric (CD25) monoclonal antibody SDZ CHI 621 in renal transplantation;Kovarik;Transplant Proc,1996
4. Strategies to improve the immunologic management of organ transplants;Halloran;Clin Transplant,1995
5. Rapamycin (AY-22,989), a new antifungal antibiotic: fermentation, isolation and characterization;Sehgal;J Antibiot (Tokyo),1975